Q1 2025 Kamada Ltd Earnings Call Transcript

May 14, 2025 / 12:30 PM GMT

Release Date Price: ₪25.17 (+2.78%)

Transcript

Key Points

Positve

Kamada Ltd (KMDA) reported a strong first quarter with total revenues of $44 million, marking a 17% increase year over year.
The company achieved a significant 54% year-over-year increase in adjusted EBITDA, reaching $11.6 million.
Kamada Ltd (KMDA) reiterated its 2025 annual guidance, projecting annual revenues between $178 million to $182 million and adjusted EBITDA between $38 million to $42 million.
The company is advancing its four-pillar growth strategy, which includes organic commercial growth, business development, M&A transactions, and plasma collection operations.
Kamada Ltd (KMDA) expanded its plasma collection operation with a new center in San Antonio, Texas, expected to contribute significantly to annual revenues.

Negative

Cytogam was not a major contributor to growth this quarter, indicating potential challenges in its market performance.
The company faces uncertainties related to global trade tariffs, although currently, no direct impact is anticipated.
There is a significant increase in the reported tax rate, from 3% to 40%, although it was noted as a non-cash expense.
Enrollment for the phase 3 inhaled Alpha 1 program is only at 55%, indicating potential delays in reaching full enrollment.
The company is still utilizing net operating losses (NOLs) and expects to start paying taxes by the end of 2025 or early 2026, which could impact future cash flows.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

KMDA.OQ - Kamada Ltd
Q1 2025 Kamada Ltd Earnings Call
May 14, 2025 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to the Comma 1st quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance, please press 0 on your telephone keypad.

As a reminder, this conference is being recorded. It is now my pleasure to introduce Brian Ritchie with Lifesty Advisors.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you. This is Brian Richie with Lifesty Advisors, and thank you all for participating in today's call.

Joining me from

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.